Advanced search
Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 42, 2018 - Issue 3
Submit an article Journal homepage
164
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

Life-Threatening Drug-Induced Liver Injury in a Patient with β-Thalassemia Major and Severe Iron Overload on Polypharmacy

Maddalena CasaleDepartment of Women, Child and General and Specialized Surgery, University of Campania ‘Luigi Vanvitelli’, Naples, Italy; Correspondence[email protected]
,
Stefania PicarielloDepartment of Women, Child and General and Specialized Surgery, University of Campania ‘Luigi Vanvitelli’, Naples, Italy;
,
Felice CorvinoDepartment of Women, Child and General and Specialized Surgery, University of Campania ‘Luigi Vanvitelli’, Naples, Italy;
,
Giuseppe CerasariLiver Unit, Hospital ‘San Camillo Forlanini’, Rome, Italy;
,
Saverio ScianguettaDepartment of Women, Child and General and Specialized Surgery, University of Campania ‘Luigi Vanvitelli’, Naples, Italy;
,
Francesca RossiDepartment of Women, Child and General and Specialized Surgery, University of Campania ‘Luigi Vanvitelli’, Naples, Italy;
,
Marcello PersicoInternal Medicine and Hepatology Unit, Hospital ‘Da Procida-AOU-San Giovanni e Ruggi D’Aragona’, University of Salerno, Salerno, Italy
&
Silverio PerrottaDepartment of Women, Child and General and Specialized Surgery, University of Campania ‘Luigi Vanvitelli’, Naples, Italy;
show all
Pages 213-216 | Received 21 May 2018, Accepted 09 Jul 2018, Published online: 25 Sep 2018

References

  • Origa R. β–Thalassemia. Genet Med. 2017;19(6):609–619.
  • Voskaridou E, Ladis V, Kattamis A, et al. A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births. Ann Hematol. 2012;91(9):1451–1458.
  • Ramaswami A, Rosen DJ, Chu J, et al. Fulminant liver failure in a child with β-Thalassemia on Deferasirox: A Case Report. J Pediatr Hematol Oncol. 2017;39(3):235–237.
  • Pennell DJ, Udelson JE, Arai AE, et al. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013. 2013;128(3):281–308. [Erratum in: Circulation. 2013;128(13):e203.]
  • Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470.
  • Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950–966.
  • Dessì C, Leoni G, Moi P, et al. Thalassemia major between liver and heart: where we are now. Blood Cells Mol Dis. 2015;55(1):82–88.
  • Fisher SA, Brunskill SJ, Doree C, et al. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia. Cochrane Database Syst Rev. 2013b;8:CD004450.
  • Fisher SA, Brunskill SJ, Doree C, et al. Oral deferiprone for iron chelation in people with thalassaemia. Cochrane Database Syst Rev. 2013a;8:CD004839.
  • FDA drug prescribing information for ferriprox 2011. Available online at: www.accessdata.fda.gov/drugsatfda_docs/label/2011/021825lbl.pdf 2011.
  • Huang WF, Chou HC, Tsai YW, et al. Safety of deferasirox: a retrospective cohort study on the risks of gastrointestinal, liver and renal events. Pharmacoepidemiol Drug Saf. 2014;23(11):1176–1182.
  • Chaudhry S, Oelsner D. Cholestatic reaction to warfarin. Am J Gastroenterol. 1995;90(5):853.
  • http://livertox.nih.gov/ (Accessed 21 May 2018).
  • Economou M, Printza N, Teli A, et al. Renal dysfunction in patients with β-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox. Acta Haematol. 2010;123(3):148–152.
  • Alonso A, MacLehose RF, Chen LY, et al. Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation. Heart. 2017;103(11):834–839.
  • Auger D, Pennell DJ. Cardiac complications in thalassemia major. Ann N Y Acad Sci. 2016;1368(1):56–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.